PATRICIA NICHOLS: Open Payments
NPI 1689865701 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 56 payments from 8 companies in 2025. Trend: 2023 $856 · 2024 $1,106 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $256 |
| Janssen Biotech, Inc. | 25 | $207 |
| ABBVIE INC. | 19 | $164 |
| GENZYME CORPORATION | 2 | $46 |
| Organon LLC | 2 | $20 |
| REVANCE THERAPEUTICS, INC. | 1 | $19 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $17 |
| UCB, Inc. | 1 | $14 |
Products named: EBGLYSS, TREMFYA, RINVOQ, SKYRIZI, DUPIXENT, TALTZ, HADLIMA, BOTOX.
Industry payments across WA — which companies pay providers there.
